160 related articles for article (PubMed ID: 29524179)
21. Dual targeting of IGF-1R and PDGFR inhibits proliferation in high-grade gliomas cells and induces radiosensitivity in JNK-1 expressing cells.
Carapancea M; Cosaceanu D; Budiu R; Kwiecinska A; Tataranu L; Ciubotaru V; Alexandru O; Banita M; Pisoschi C; Bäcklund ML; Lewensohn R; Dricu A
J Neurooncol; 2007 Dec; 85(3):245-54. PubMed ID: 17568996
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor-1 receptor (IGF-1R) expression does not predict for resistance to trastuzumab-based treatment in patients with Her-2/neu overexpressing metastatic breast cancer.
Köstler WJ; Hudelist G; Rabitsch W; Czerwenka K; Müller R; Singer CF; Zielinski CC
J Cancer Res Clin Oncol; 2006 Jan; 132(1):9-18. PubMed ID: 16184380
[TBL] [Abstract][Full Text] [Related]
23. [Nuclear expression of Survivin in glioma and its correlation to prognosis].
Pan Y; Hu WH; Xie D; Wu HX; Xiang J; Liu YD; Wu QL; Liu YH
Ai Zheng; 2006 May; 25(5):635-9. PubMed ID: 16687089
[TBL] [Abstract][Full Text] [Related]
24. Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer.
Codony-Servat J; Cuatrecasas M; Asensio E; Montironi C; Martínez-Cardús A; Marín-Aguilera M; Horndler C; Martínez-Balibrea E; Rubini M; Jares P; Reig O; Victoria I; Gaba L; Martín-Richard M; Alonso V; Escudero P; Fernández-Martos C; Feliu J; Méndez JC; Méndez M; Gallego J; Salud A; Rojo F; Castells A; Prat A; Rosell R; García-Albéniz X; Camps J; Maurel J
Br J Cancer; 2017 Dec; 117(12):1777-1786. PubMed ID: 29123263
[TBL] [Abstract][Full Text] [Related]
25. The basic route of nuclear-targeted transport of IGF-1/IGF-1R and potential biological functions in intestinal epithelial cells.
Xiu M; Huan X; Ou Y; Ying S; Wang J
Cell Prolif; 2021 Jun; 54(6):e13030. PubMed ID: 33932050
[TBL] [Abstract][Full Text] [Related]
26. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
[TBL] [Abstract][Full Text] [Related]
27. Concentrations of IGF-I and IGFBP-3 and brain tumor risk in the European Prospective Investigation into Cancer and Nutrition.
Rohrmann S; Linseisen J; Becker S; Allen N; Schlehofer B; Overvad K; Olsen A; Tjønneland A; Melin BS; Lund E; Vineis P; Grioni S; Tumino R; Palli D; Mattiello A; Bonet C; Chirlaque MD; Sánchez MJ; Rodríguez L; Dorronsoro M; Ardanaz E; Lagiou P; Trichopoulou A; Trichopoulos D; Dossus L; Grote VA; Boeing H; Aleksandrova K; Bueno-de-Mesquita HB; van Duijnhoven FJ; Peeters PH; Khaw KT; Wareham NJ; Key TJ; Rinaldi S; Romieux I; Gallo V; Michaud DS; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2174-82. PubMed ID: 21788435
[TBL] [Abstract][Full Text] [Related]
28. The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients.
Yang X; Li D; Cheng S; Fan K; Sheng L; Zhang J; Feng B; Xu Z
Tumour Biol; 2014 Nov; 35(11):11091-5. PubMed ID: 25099618
[TBL] [Abstract][Full Text] [Related]
29. Thioredoxin System Protein Expression Is Associated with Poor Clinical Outcome in Adult and Paediatric Gliomas and Medulloblastomas.
Yao A; Storr SJ; Al-Hadyan K; Rahman R; Smith S; Grundy R; Paine S; Martin SG
Mol Neurobiol; 2020 Jul; 57(7):2889-2901. PubMed ID: 32418115
[TBL] [Abstract][Full Text] [Related]
30. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
[TBL] [Abstract][Full Text] [Related]
31. Impact of IGF-1, IGF-1R, and IGFBP-3 promoter methylation on the risk and prognosis of esophageal carcinoma.
Ye P; Qu CF; Hu XL
Tumour Biol; 2016 May; 37(5):6893-904. PubMed ID: 26662570
[TBL] [Abstract][Full Text] [Related]
32. Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer.
Kim JS; Kim ES; Liu D; Lee JJ; Behrens C; Lippman SM; Hong WK; Wistuba II; Lee E; Lee HY
Oncotarget; 2015 Jun; 6(18):16746-56. PubMed ID: 25944691
[TBL] [Abstract][Full Text] [Related]
33. IGF-1R and Bmi-1 expressions in lung adenocarcinoma and their clinicopathologic and prognostic significance.
Zhang X; Sun J; Wang H; Lou Y; Zhang Y; Sha H; Feng J; Han B
Tumour Biol; 2014 Jan; 35(1):739-45. PubMed ID: 23990442
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.
Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X
J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554
[TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial.
Gennari A; Foca F; Zamarchi R; Rocca A; Amadori D; De Censi A; Bologna A; Cavanna L; Gianni L; Scaltriti L; Rossi E; Facchinetti A; Martini V; Bruzzi P; Nanni O
Breast Cancer Res Treat; 2020 May; 181(1):61-68. PubMed ID: 32200486
[TBL] [Abstract][Full Text] [Related]
36. Utility of combining OLIG2 and SOX10 IHC expression in CNS tumours: promising biomarkers for subtyping paediatric- and adult-type gliomas.
Aboubakr O; Métais A; Maillard J; Hasty L; Brigot E; Berthaud C; Lacombe J; Pucelle N; Raynal J; Appay R; Varlet P; Tauziède-Espariat A
Histopathology; 2024 Apr; 84(5):893-899. PubMed ID: 38253970
[TBL] [Abstract][Full Text] [Related]
37. Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations.
Yeo CD; Park KH; Park CK; Lee SH; Kim SJ; Yoon HK; Lee YS; Lee EJ; Lee KY; Kim TJ
Lung Cancer; 2015 Mar; 87(3):311-7. PubMed ID: 25617986
[TBL] [Abstract][Full Text] [Related]
38. MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas.
Shi ZM; Wang XF; Qian X; Tao T; Wang L; Chen QD; Wang XR; Cao L; Wang YY; Zhang JX; Jiang T; Kang CS; Jiang BH; Liu N; You YP
RNA; 2013 Apr; 19(4):552-60. PubMed ID: 23431408
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R.
Guo T; Feng Y; Liu Q; Yang X; Jiang T; Chen Y; Zhang Q
Tumour Biol; 2014 Nov; 35(11):11269-75. PubMed ID: 25117070
[TBL] [Abstract][Full Text] [Related]
40. Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes.
Yerushalmi R; Gelmon KA; Leung S; Gao D; Cheang M; Pollak M; Turashvili G; Gilks BC; Kennecke H
Breast Cancer Res Treat; 2012 Feb; 132(1):131-42. PubMed ID: 21574055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
